Finally, certain canonical lymphoma genetic lesions such as BCL2 and MYC translocations may be explained as a way to bypass their transcriptional repression by BCL6.48 This leads to a situation where BCL6 pro‐tumor functions are preserved, while its antitumor functions are abrogated. The gene discussed is MYC; the disease is lymphoma.